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ABSTRACT
The first total synthesis of (–)-lemonomycin has been accomplished in an efficient
and convergent manner.  The synthesis features a highly diastereoselective, auxiliary-
controlled dipolar cycloaddition that forms the bicyclic core and set the absolute
stereochemistry of the natural product.  The resulting diazabicycle was advanced by
Suzuki coupling, diastereoselective hydrogenation, and a highly convergent, completely
diastereoselective Pictet-Spengler cyclization with a glycosyloxy-acetaldehyde.  The
Pictet-Spengler product was then converted to (–)-lemonomycin in three steps.  The
glycosyl portion of lemonomycin was synthesized diastereoselectively from D-threonine.
The synthesis of (+)-cyanocycline A has been approached along two synthetic
routes.  Progress along a silyl ether route led to the discovery of a new diastereoselective
hydrogenation of an unsaturated diazabicyclic to set the C(4) stereochemistry of
cyanocycline A.  The product of this reduction was advanced through a convergent Stille
coupling reaction to an enamide that contains all but six of the heavy atoms of
cyanocycline A with the correct stereochemistry at each of the stereogenic carbons.
Further, the enamide functionality is an ideal precursor for installation of the C(13b)
amino group.
Progress along an oxazoline route has led to the development of a novel dipolar
cycloaddition of an alkynyl oxazoline.  The resulting diazabicycle was advanced through
a convergent Stille coupling reaction and diastereoselective hydrogenation to a late stage
intermediate that contains all but three of the heavy atoms of cyanocycline A and has the
correct relative stereochemistry for cyanocycline A.
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